Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Mary Sansone is a two-time survivor of acute myeloid leukemia. Compensate for all of Mary's blogs right here!My ardour is to really feel passionate....
When making ready sufferers with a number of myeloma to start remedy, healthcare suppliers focus closely on schooling and help. The preliminary analysis...
